Related Experiment Videos
Cerebral postischemic hyperperfusion assessed by Xenon-133 SPECT
Y R Tran Dinh1, O Ille, J P Guichard
1Department of Functional Nervous System Imaging, Hôpital Lariboisière, Paris, France.
Summary
Cerebral postischemic hyperperfusion (CPH) does not significantly impact clinical outcomes in stroke patients. Hemodynamics in CPH patients generally remain normal, and asymmetry does not predict clinical evolution.
Area of Science:
- Neurology
- Radiology
- Vascular Medicine
Background:
- Cerebral postischemic hyperperfusion (CPH) is a complex phenomenon following ischemic stroke.
- Understanding its functional and clinical implications is crucial for patient management.
Purpose of the Study:
- To evaluate the functional and clinical evolution of CPH.
- To compare cerebral blood flow (CBF) and vasoreactivity in patients with and without CPH.
Main Methods:
- Studied 44 patients with unilateral cerebral ischemia.
- Utilized 133Xe-SPECT for CBF measurement and acetazolamide for vasoreactivity testing.
- Compared clinical outcomes using the NIH Stroke Scale.
Main Results:
- CPH correlated with CT abnormalities in 57% of cases.
- 80% of CPH patients showed normal cerebral hemodynamics; 20% had local vasoplegia.
- No significant difference in clinical scores between CPH and non-CPH groups was observed.
Conclusions:
- CPH does not appear to interfere with clinical evolution.
- Interhemispheric asymmetry is not a reliable predictor of clinical outcome in CPH patients.
- Cerebral hemodynamics are typically normal in most CPH cases.